Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review Georgia E. RitchieMangalee FernandoDavid Goldstein Review Article 06 August 2016 Pages: 1 - 7
Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial Michel DucreuxJaafar BennounaAlfredo Romano Original Article 19 November 2016 Pages: 9 - 16
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors James SpicerSheeba IrshadJohann de Bono Original Article Open access 21 November 2016 Pages: 17 - 27
Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study) Masato NakamuraToru AoyamaHideyuki Mishima Original Article Open access 22 November 2016 Pages: 29 - 36
Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact Yoshiaki MurakamiKenichiro UemuraTaijiro Sueda Original Article 22 November 2016 Pages: 37 - 47
Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma Hui ZhangYan GuoChao Shang Original Article 22 November 2016 Pages: 49 - 55
Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration S. Kenneth SyTheresa D. SweeneyMichael A. Eldon Original Article Open access 30 November 2016 Pages: 57 - 67
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway Ming-ming HeDong-sheng ZhangRui-hua Xu Original Article Open access 02 December 2016 Pages: 69 - 79
Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma Sung Won LeeHae Lim LeeSeung Kew Yoon Original Article 02 December 2016 Pages: 81 - 88
A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors Toshihiko DoiNozomu FuseAtsushi Ohtsu Original Article Open access 03 December 2016 Pages: 89 - 98
The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas Young Saing KimSung Yong OhJoung-Soon Jang Original Article 07 December 2016 Pages: 99 - 106
Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer Takayuki YoshinoIchinosuke HyodoNarikazu Boku Original Article 08 December 2016 Pages: 107 - 116
Synergistic disruption of ERα/HER2 crosstalk by endoxifen and lapatinib in breast cancer cells James Chun Yip ChanPei Shi OngEric Chun Yong Chan Original Article 09 December 2016 Pages: 117 - 130
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer Shunji TakahashiTakayuki KobayashiTaito Esaki Original Article Open access 09 December 2016 Pages: 131 - 138
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor Changhoon YooHyungwoo ChoBaek-Yeol Ryoo Original Article 10 December 2016 Pages: 139 - 146
Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104) Hironaga SatakeMasaaki IwatsukiKyushu Study Group of Clinical Cancer Original Article Open access 10 December 2016 Pages: 147 - 153
A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma Margarita B. BelogurovaZoryana P. KizymaAndreas Lammerich Original Article Open access 16 December 2016 Pages: 155 - 164
Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer Kyoichi KairaYoshio TomizawaTakeshi Hisada Original Article 19 December 2016 Pages: 165 - 171
Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma Ji Young LeeCheryn SongJae Lyun Lee Original Article 23 December 2016 Pages: 173 - 180
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium Frank M. BalisPatrick A. ThompsonElizabeth Fox Original Article Open access 28 December 2016 Pages: 181 - 187
Population pharmacokinetics of lenalidomide in multiple myeloma patients Beatriz Guglieri-LópezAlejandro Pérez-PitarchMatilde Merino-Sanjuán Original Article 30 December 2016 Pages: 189 - 200
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies Charles A. KunosEdward ChuS. Percy Ivy Clinical Trial Report 22 November 2016 Pages: 201 - 207
Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis Hisao ImaiKyoichi KairaMasanobu Yamada Short Communication 29 November 2016 Pages: 209 - 213
Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure Kim DaoYimin LuSebastien Kissling Short Communication 17 December 2016 Pages: 215 - 218